KIR2DL3 and KIR2DL1 show similar impact on licensing of human NK cells

European Journal of Immunology

Volumn 46, Issue 1, 2016, Pages 185-191

  Sim, Malcolm J W ^a,b   Stowell, Janet ^a   Sergeant, Ruhena ^a   Altmann, Daniel M ^a   Long, Eric O ^b   Boyton, Rosemary J ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Human leukocyte antigen (HLA); Killer immunoglobulin like receptor (KIR); Licensing; NK cell (NKC); Rheostat model

Indexed keywords

HLA ANTIGEN CLASS 1; HLA C ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL3; LIGAND; KIR2DL1 PROTEIN, HUMAN; KIR2DL3 PROTEIN, HUMAN;

ALLOTYPE; ARTICLE; CONTROLLED STUDY; DEGRANULATION; FLOW CYTOMETRY; GENOTYPE; HUMAN; HUMAN CELL; NATURAL KILLER CELL; NORMAL HUMAN; PRIORITY JOURNAL; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION;

FLOW CYTOMETRY; HLA-C ANTIGENS; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; RECEPTORS, KIR2DL1; RECEPTORS, KIR2DL3;

EID: 84953838303     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201545757     Document Type: Article

References (38)

1. Long, E. O., Sik Kim, H., Liu, D., Peterson, M. E. and Rajagopalan, S., Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu. Rev. Immunol. 2013. 31: 227-258.
2. Parham, P., MHC class I molecules and KIRs in human history, health and survival. Nat. Rev. Immunol. 2005. 5: 201-214.
3. Long, E. O., Negative signaling by inhibitory receptors: the NK cell paradigm. Immunol. Rev. 2008. 224: 70-84.
4. Burshtyn, D. N., Scharenberg, A. M., Wagtmann, N., Rajagopalan, S., Berrada, K., Yi, T., Kinet, J. P. et al., Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. Immunity 1996. 4: 77-85.
5. Kim, S., Poursine-Laurent, J., Truscott, S. M., Lybarger, L., Song, Y. J., Yang, L., French, A. R. et al., Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 2005. 436: 709-713.
6. Anfossi, N., Andre, P., Guia, S., Falk, C. S., Roetynck, S., Stewart, C. A., Breso, V. et al., Human NK cell education by inhibitory receptors for MHC class I. Immunity 2006. 25: 331-342.
7. Brodin, P., Karre, K. and Hoglund, P., NK cell education: not an on-off switch but a tunable rheostat. Trends Immunol. 2009. 30: 143-149.
8. Kim, H. S., Das, A., Gross, C. C., Bryceson, Y. T. and Long, E. O., Synergistic signals for natural cytotoxicity are required to overcome inhibition by c-Cbl ubiquitin ligase. Immunity 2010. 32: 175-186.
9. Bryceson, Y. T., March, M. E., Ljunggren, H. G. and Long, E. O., Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 2006. 107: 159-166.
10. Brodin, P., Lakshmikanth, T., Johansson, S., Karre, K. and Hoglund, P., The strength of inhibitory input during education quantitatively tunes the functional responsiveness of individual natural killer cells. Blood 2009. 113: 2434-2441.
11. Joncker, N. T., Fernandez, N. C., Treiner, E., Vivier, E. and Raulet, D. H., NK cell responsiveness is tuned commensurate with the number of inhibitory receptors for self-MHC class I: the rheostat model. J. Immunol. 2009. 182: 4572-4580.
12. Parham, P. and Moffett, A., Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution. Nat. Rev. Immunol. 2013. 13: 133-144.
13. Parham, P., Norman, P. J., Abi-Rached, L. and Guethlein, L. A., Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules. Philos. Trans R. Soc. Lond. B Biol. Sci. 2012. 367: 800-811.
14. Middleton, D. and Gonzelez, F., The extensive polymorphism of KIR genes. Immunology 2010. 129: 8-19.
15. Moretta, A., Vitale, M., Bottino, C., Orengo, A. M., Morelli, L., Augugliaro, R., Barbaresi, M. et al., P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J. Exp. Med. 1993. 178: 597-604.
16. Colonna, M., Borsellino, G., Falco, M., Ferrara, G. B. and Strominger, J. L., HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. Proc. Natl. Acad. Sci. USA 1993. 90: 12000-12004.
17. Moesta, A. K., Norman, P. J., Yawata, M., Yawata, N., Gleimer, M. and Parham, P., Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3. J. Immunol. 2008. 180: 3969-3979.
18. Winter, C. C., Gumperz, J. E., Parham, P., Long, E. O. and Wagtmann, N., Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. J. Immunol. 1998. 161: 571-577.
19. Gumperz, J. E., Litwin, V., Phillips, J. H., Lanier, L. L. and Parham, P., The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J. Exp. Med. 1995. 181: 1133-1144.
20. Older Aguilar, A. M., Guethlein, L. A., Adams, E. J., Abi-Rached, L., Moesta, A. K. and Parham, P., Coevolution of killer cell Ig-like receptors with HLA-C to become the major variable regulators of human NK cells. J. Immunol. 2010. 185: 4238-4251.
21. Boyton, R. J. and Altmann, D. M., Natural killer cells, killer immunoglobulin-like receptors and human leucocyte antigen class I in disease. Clin. Exp. Immunol. 2007. 149: 1-8.
22. Khakoo, S. I., Thio, C. L., Martin, M. P., Brooks, C. R., Gao, X., Astemborski, J., Cheng, J. et al., HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 2004. 305: 872-874.
23. Rajagopalan, S. and Long, E. O., Understanding how combinations of HLA and KIR genes influence disease. J. Exp. Med. 2005. 201: 1025-1029.
24. Khakoo, S. I. and Carrington, M., KIR and disease: a model system or system of models? Immunol. Rev. 2006. 214: 186-201.
25. Waggoner, S. N., Cornberg, M., Selin, L. K. and Welsh, R. M., Natural killer cells act as rheostats modulating antiviral T cells. Nature 2012. 481: 394-398.
26. Crouse, J., Xu, H. C., Lang, P. A. and Oxenius, A., NK cells regulating T cell responses: mechanisms and outcome. Trends Immunol. 2014. 36: 49-58.
27. Horowitz, A., Strauss-Albee, D. M., Leipold, M., Kubo, J., Nemat-Gorgani, N., Dogan, O. C., Dekker, C. L. et al., Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry. Sci. Transl. Med. 2013. 5: 208ra145.
28. Yawata, M., Yawata, N., Draghi, M., Partheniou, F., Little, A. M. and Parham, P., MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response. Blood 2008. 112: 2369-2380.
29. Lopez-Verges, S., Milush, J. M., Schwartz, B. S., Pando, M. J., Jarjoura, J., York, V. A., Houchins, J. P. et al., Expansion of a unique CD57(+)NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc. Natl. Acad. Sci. USA 2011. 108: 14725-14732.
30. Fauriat, C., Ivarsson, M. A., Ljunggren, H. G., Malmberg, K. J. and Michaelsson, J., Education of human natural killer cells by activating killer cell immunoglobulin-like receptors. Blood 2010. 115: 1166-1174.
31. Charoudeh, H. N., Schmied, L., Gonzalez, A., Terszowski, G., Czaja, K., Schmitter, K., Infanti, L. et al., Quantity of HLA-C surface expression and licensing of KIR2DL+ natural killer cells. Immunogenetics 2012. 64: 739-745.
32. Kim, S., Sunwoo, J. B., Yang, L., Choi, T., Song, Y. J., French, A. R., Vlahiotis, A. et al., HLA alleles determine differences in human natural killer cell responsiveness and potency. Proc. Natl. Acad. Sci. USA 2008. 105: 3053-3058.
33. Joncker, N. T. and Raulet, D. H., Regulation of NK cell responsiveness to achieve self-tolerance and maximal responses to diseased target cells. Immunol. Rev. 2008. 224: 85-97.
34. Joncker, N. T., Shifrin, N., Delebecque, F. and Raulet, D. H., Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment. J. Exp. Med. 2010. 207: 2065-2072.
35. Fauriat, C., Andersson, S., Björklund, A. T., Carlsten, M., Schaffer, M., Björkström, N. K., Baumann, B. C. et al., Estimation of the size of the alloreactive NK cell repertoire: studies in individuals homozygous for the group A KIR haplotype. J. Immunol. 2008. 1(181): 6010-6019.
36. Yu, J., Heller, G., Chewning, J., Kim, S., Yokoyama, W. M. and Hsu, K. C., Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands. J. Immunol. 2007. 179: 5977-5989.
37. Cassidy, S., Mukherjee, S., Myint, T. M., Mbiribindi, B., North, H., Traherne, J., Mulder, A. et al., Peptide selectivity discriminates NK cells from KIR2DL2- and KIR2DL3-positive individuals. Eur. J. Immunol. 2015. 45: 492-500.
38. Beziat, V., Traherne, J., Malmberg, J. A., Ivarsson, M. A., Bjorkstrom, N. K., Retiere, C., Ljunggren, H. G. et al., Tracing dynamic expansion of human NK-cell subsets by high-resolution analysis of KIR repertoires and cellular differentiation. Eur. J. Immunol. 2014. 44: 2192-2196.